Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Halfmann

Showing results (1-10 of 59) with videos related to

Pageof 6
Sort By:
Plos Pathogens|October 14, 2020
HER2-mediated enhancement of Ebola virus entryMakoto Kuroda, Peter Halfmann, Yoshihiro Kawaoka
The Journal of Infectious Diseases|October 12, 2011
The Ebolavirus VP24 protein blocks phosphorylation of p38 mitogen-activated protein kinasePeter Halfmann, Gabriele Neumann, Yoshihiro Kawaoka
The Journal of Infectious Diseases|July 31, 2018
The Induction of IL-1β Secretion Through the NLRP3 Inflammasome During Ebola Virus InfectionPeter Halfmann, Lindsay Hill-Batorski, Yoshihiro Kawaoka
The Journal of Infectious Diseases|December 6, 2007
Regions in Ebola virus VP24 that are important for nucleocapsid formationTakeshi Noda, Peter Halfmann, Hiroshi Sagara, et al.
Virology|May 30, 2002
Human influenza a viral genes responsible for the restriction of its replication in duck intestineMasato Hatta, Peter Halfmann, Krisna Wells, et al.
Scientific Reports|February 6, 2013
The spatio-temporal distribution dynamics of Ebola virus proteins and RNA in infected cellsAsuka Nanbo, Shinji Watanabe, Peter Halfmann, et al.
Journal of Virology|October 11, 2013
The cytoprotective enzyme heme oxygenase-1 suppresses Ebola virus replicationLindsay Hill-Batorski, Peter Halfmann, Gabriele Neumann, et al.
Biotechnology and Bioengineering|July 11, 2020
Formulation and production of a blood-free and chemically defined virus production media for VERO cellsRandall Alfano, Atherly Pennybaker, Peter Halfmann, et al.
The Journal of Infectious Diseases|December 6, 2007
Ebola virus (EBOV) VP24 inhibits transcription and replication of the EBOV genomeShinji Watanabe, Takeshi Noda, Peter Halfmann, et al.
Frontiers in Cell and Developmental Biology|September 28, 2020
Repurposing Fragile X Drugs to Inhibit SARS-CoV-2 Viral ReproductionCara J Westmark, Maki Kiso, Peter Halfmann, et al.
Pageof 6

Showing results (1-10 of 59) with videos related to

Sort By:
Pageof 6
Plos Pathogens|October 14, 2020
HER2-mediated enhancement of Ebola virus entryMakoto Kuroda, Peter Halfmann, Yoshihiro Kawaoka
The Journal of Infectious Diseases|October 12, 2011
The Ebolavirus VP24 protein blocks phosphorylation of p38 mitogen-activated protein kinasePeter Halfmann, Gabriele Neumann, Yoshihiro Kawaoka
The Journal of Infectious Diseases|July 31, 2018
The Induction of IL-1β Secretion Through the NLRP3 Inflammasome During Ebola Virus InfectionPeter Halfmann, Lindsay Hill-Batorski, Yoshihiro Kawaoka
The Journal of Infectious Diseases|December 6, 2007
Regions in Ebola virus VP24 that are important for nucleocapsid formationTakeshi Noda, Peter Halfmann, Hiroshi Sagara, et al.
Virology|May 30, 2002
Human influenza a viral genes responsible for the restriction of its replication in duck intestineMasato Hatta, Peter Halfmann, Krisna Wells, et al.
Scientific Reports|February 6, 2013
The spatio-temporal distribution dynamics of Ebola virus proteins and RNA in infected cellsAsuka Nanbo, Shinji Watanabe, Peter Halfmann, et al.
Journal of Virology|October 11, 2013
The cytoprotective enzyme heme oxygenase-1 suppresses Ebola virus replicationLindsay Hill-Batorski, Peter Halfmann, Gabriele Neumann, et al.
Biotechnology and Bioengineering|July 11, 2020
Formulation and production of a blood-free and chemically defined virus production media for VERO cellsRandall Alfano, Atherly Pennybaker, Peter Halfmann, et al.
The Journal of Infectious Diseases|December 6, 2007
Ebola virus (EBOV) VP24 inhibits transcription and replication of the EBOV genomeShinji Watanabe, Takeshi Noda, Peter Halfmann, et al.
Frontiers in Cell and Developmental Biology|September 28, 2020
Repurposing Fragile X Drugs to Inhibit SARS-CoV-2 Viral ReproductionCara J Westmark, Maki Kiso, Peter Halfmann, et al.
Pageof 6